PAYAL SHAH
TEANECK, NJ NPI 1962406504
Browse related groups: NJ Myriad Women's Health, Inc. All categories
General Payments — all program years on this page
$1,903.19
- Category: General Payments
- Program years: PY2018–2023
- Record count: 55
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $351.00 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $351.00 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Myriad Women's Health, Inc. | $246.58 | 2 |
| Astellas Pharma US Inc | $42.23 | 2 |
| Exact Sciences Corporation | $29.95 | 2 |
| Pacira Pharmaceuticals Incorporated | $16.69 | 1 |
| Meditrina | $15.55 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1026728083 | Exact Sciences Corporation | $16.98 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1026728233 | Exact Sciences Corporation | $12.97 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1033939003 | Astellas Pharma US Inc | $19.12 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1034187127 | Astellas Pharma US Inc | $23.11 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1041533101 | Pacira Pharmaceuticals Incorporated | $16.69 | 10/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1052371303 | Meditrina | $15.55 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059587703 | Myriad Women's Health, Inc. | $88.93 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059587709 | Myriad Women's Health, Inc. | $157.65 | 12/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.